Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,131 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200B 1765 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| D Databricks provides a cloud data warehouse and AI software products. | $5B | Growth | AI | United States | Investors | |
| KT Khartis TherapeuticsCompany profile Develops oral small molecule therapies for immunological and chronic diseases Develops oral small molecule therapies for immunological and chronic diseases | $50M | Series B | Biotech | United States | Investors | |
| HI Heaviside IndustriesCompany profile Builds autonomous precision munitions platforms for air, land, and sea forces Builds autonomous precision munitions platforms for air, land, and sea forces | $60M | Series B | Defense tech | United States | Investors | |
| EF Provides technology and capital access for consumer credit lending markets | Undisclosed | Growth | Fintech | United States | Investors | |
| R ReservoirCompany profile Reservoir makes and installs predictive all-electric water heaters designed to serve homeowners and respond to energy needs. Reservoir makes and installs predictive all-electric water heaters designed to serve homeowners and respond to energy needs. | $8M | Seed | Climate tech | United States | Investors | |
| AH Amplifica Holdings GroupCompany profile Amplifica develops injectable drug candidates intended to reactivate hair follicles in people with androgenetic alopecia. Amplifica develops injectable drug candidates intended to reactivate hair follicles in people with androgenetic alopecia. | $26M | Series B | Biotech | United States | Investors | |
| I InduProCompany profile Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease | $77M | Series B | Biotech | United States | Investors | |
| DP Digital Prime TechnologiesCompany profile Provides institutional technology for digital asset and tokenized asset lending Provides institutional technology for digital asset and tokenized asset lending | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors | |
| C ClearJetCompany profile Connects shippers to unused commercial flight cargo space for faster package delivery Connects shippers to unused commercial flight cargo space for faster package delivery | $25M | Growth | Logistics | United States | Investors | |
| Bt Bridge to LifeCompany profile Makes organ preservation and perfusion technology for liver transplants Makes organ preservation and perfusion technology for liver transplants | $110M | Series C+DebtUndisclosed | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.